Elevated liver fat content is independently associated with insulin resistance in people with type 1 diabetes
Source
JHEP Reports - ISSN 2589-5559-8:8 (2026) p.
Assessing Europe's policy readiness to confront the MASLD/MASH public health threat
Source
The Lancet regional health. Europe - ISSN 2666-7762-65 (2026) p.
Steatotic liver disease trajectory : a holistic EASL guidance on the multidisciplinary approach to screening and patient management
Source
JHEP Reports - ISSN 2589-5559
The role and reversibility of vascular alterations in the development, progression and regression of metabolic dysfunction-associated steatotic liver disease (MASLD)
Source
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2026,259 p.
MASLD, MASH, and the CKM spectrum : a roadmap for multiorgan clinical trial design
Source
Journal of the American College of Cardiology - ISSN 0735-1097-87:15 (2026) p. 2006-2033